Driv celebrates March 8th: Endometriosis – from silence to action at Litteraturhuset in Bergen
On International Women's Day itself, March 8th, DRIV organized an engaging panel debate on endometriosis at the Literature House in Bergen. The venue was packed, and the discussion brought together a range of experts to share knowledge, experiences, and perspectives
Main content
To provide more tailored treatments, there is still much work to be done. Researchers at the University of Bergen (UiB) will collaborate with clinicians to analyze patient data and uncover new knowledge. The goal is to better understand the causes of endometriosis and discover new ways to treat the disease. This could open doors to more effective and personalized care for women living with endometriosis.
Why is this important?
Endometriosis is a complex condition that remains underdiagnosed and undertreated. Through research and user involvement, we can improve current treatment options and offer hope for a better future for affected women.
Collaboration is key.
By bringing researchers, clinicians, and patients closer together, we ensure that new knowledge translates into real-world solutions for those who need it.
This is an important step toward more comprehensive and effective healthcare.
Thank you to everyone who contributed! A special thanks to the panel:
Marion Solheim: Moderator, University of Bergen (UiB)
Hildegunn Lid Meidell: Peer support representative from the Endometriosis Association of Norway
Agnete S. T. Engelsen: Researcher at the Centre for Cancer Biomarkers (CCBIO)
Anne Veddeng: Senior Consultant, Gynecologist, and Endometriosis Specialist, at Haukeland University Hospital
Edel Elin Salomonsen Johannessen: General Practitioner
